The plan may conflict with the new HHS head, RFK Jr., who helped sue Monsanto over lack of sufficient health warnings.
BeiGene (ONC) has received FDA approval for Tevimbra for first-line esophageal cancer with chemo. Read more here.
Researchers at Fred Hutch Cancer Center have discovered an overlooked mechanism driving aggressive breast and brain tumors ...
An experimental medicine from Protagonist Therapeutics stabilized red blood cells and improved symptoms in patients with a ...
The number of deaths in the UK has decreased, however experts are calling for urgent government action in a specific disease ...
New data has revealed Britain's illegal vape hotspots, with some areas accounting for nearly two in five of all devices confiscated by authorities across the country.
The FDA advances in multiple cancer types, and researchers assess potential impacts of funding freezes on cancer research.
SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...
Nanotechnology is revolutionizing the field of chemotherapy by addressing critical limitations such as nonspecific cell death, chemoresistance, organ ...
He dismissed this outright. “No, it’s definitely the vaccines,” he insisted, before pivoting to his next pitch: Super Mineral ...
‘Truly game-changing’ new test backed by Sir Chris Hoy ‘diagnoses prostate cancer with 96% accuracy’
SCIENTISTS have a developed a "game-changing" new "super test" that can diagnose prostate cancer with 96 per cent accuracy. Olympic cycling legend Sir Chris Hoy - who revealed he had terminal ...
Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3,100 new brands collectively earned Rs 1,097 crore, with significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results